A new generation, fully automated coagulation analyzer with a walk-away reagent management concept
Roche Diagnostics (Schweiz) AG
Streamlining workflow and efficiency to optimize workforce productivity in coagulation laboratories
The cobas t 711 coagulation analyzer utilizes a walk-away reagent management (W.A.R.M.) concept and has demonstrated accurate and reproducible sample measurement in routine practice. Extended routine testing was faster on the cobas t 711 coagulation analyzer than on three comparator systems. Total and weekly hands-on time was negligible on the cobas t 711 coagulation analyzer. Factors associated with the W.A.R.M. concept, including high test capacity, good onboard stability, reduced reagent top-ups, automated reconstitution and scheduling of reconstitution, and automated overnight maintenance, reduced the laboratory workload and increased efficiency. All outcomes relating to quality control were slower with the cobas t 711 coagulation analyzer versus comparator analyzers. However, automated maintenance processes that require no hands-on time from laboratory staff can happen in the background and can be programmed to take place at night. Overall, these results indicate that the cobas t 711 analyzer could streamline workflow and efficiency in coagulation laboratories.
Download white paper now
A new generation, fully automated coagulation analyzer with a walk-away reagent management concept
Streamlining workflow and efficiency to optimize workforce productivity in coagulation laboratories
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.